Article 45 - ACCESS TO TREATMENTS FOR TERMINALLY ILL PATIENTS

Section 25-45-101 - Short title
Section 25-45-102 - Legislative declaration
Section 25-45-103 - Definitions
Section 25-45-104 - Drug manufacturers - availability of investigational drugs, biological products, or devices - costs - insurance coverage
Section 25-45-105 - Action against health-care provider's license or medicare certification prohibited
Section 25-45-106 - Access to investigational drugs, biological products, and devices
Section 25-45-107 - No cause of action created
Section 25-45-108 - Effect on health-care coverage